Eam Investors, LLC Chemo Centryx, Inc. Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$47.25 - $65.16 $752,787 - $1.04 Million
-15,932 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$46.35 - $61.69 $1.77 Million - $2.36 Million
-38,288 Reduced 70.62%
15,932 $873,000
Q2 2020

Aug 13, 2020
SELL
$38.58 - $65.07 $1.59 Million - $2.69 Million
-41,311 Reduced 43.24%
54,220 $3.12 Million
Q1 2020

May 13, 2020
SELL
$32.73 - $50.78 $478,119 - $741,794
-14,608 Reduced 13.26%
95,531 $3.84 Million
Q4 2019

Feb 11, 2020
BUY
$6.81 - $39.55 $750,046 - $4.36 Million
110,139 New
110,139 $4.36 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email